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cause of death in younger age groups in rural South Africa,(10) 
hypertension clearly accounts for a significant burden on health 
care in South Africa.
AbstrAct
28
HypErtEnsion 
in AfricA
IntroductIon                                                              
In economically developed countries there is considerable evidence 
for a continuous and positive relationship between blood pressure 
(BP) and both myocardial infarction and stroke.(1) The impact of BP 
on these catastrophic events extends well below currently accepted 
BP thresholds for the diagnosis of hypertension and the incremental 
risk for cardiovascular disease (CVD) with increasing BP is noted 
over a wide age range.(1) As reviewed by guideline committees for 
the diagnosis and management of hypertension,(2-4) numerous large 
clinical intervention studies have provided strong evidence to 
indicate that decreasing BP with a variety of anti-hypertensive 
agents substantially reduces the risk for cardiovascular events, thus 
establishing the role of BP as a key factor in the pathogenesis of 
CVD. More recent data derived from population or hospital-based 
studies conducted in economically developing populations including 
African populations, clearly demonstrate that in comparison to 
other cardiovascular risk factors, hypertension is the dominant risk 
factor for myocardial infarcts,(5) stroke(6-8) and heart failure of non-
ischaemic origins(9) in these communities. As these conditions are 
the leading causes of death in the elderly and the third commonest 
Hypertension may affect approximately one fifth or more of 
all adult south Africans. despite the considerable evidence 
derived from economically developed countries to indicate 
the extent to which hypertension contributes to cardio-
vascular disease (cVd), it is only more recently that data has 
emerged from the African continent to support a contention 
that hypertension is the principal risk factor for cVd in 
African populations and that cVd accounts for a major 
proportion of deaths in the elderly and in younger adults in 
rural Africa. Active engagement in the harsh realities of 
managing this complex clinical trait should therefore be 
foremost on the minds of the healthcare sector in Africa. In 
this regard there are unique challenges. 
In the present personal review we synthesise the evidence 
for or against the view that at a public health level, the 
answer to significantly reducing the burden of cVd pro-
duced by hypertension in African populations, may lie in 
something as simple as generating a healthier lifestyle. In this 
regard, we place recent evidence obtained from south 
African studies of the importance of modifiable cardiovas-
cular risk factors related to hypertension, including salt 
intake and obesity, in the context of previously published 
evidence. We highlight the very recent and the first 
substantive evidence derived from an African community 
to show that salt intake indeed contributes to a significant 
portion of blood pressure (bP) variability in African popu-
lations, but this effect may be hidden because the impact is 
largely on central (aortic) rather than brachial bP. 
We also discuss the increasing evidence to show that in 
African populations, the adverse effects of the epidemic of 
obesity that faces emerging communities is likely to ac- 
count for a substantial proportion of cardiovascular risk 
not through marked effects on brachial bP, but through 
indirect effects by promoting the adverse effects of bP on 
the heart. In the present review we therefore argue that 
despite limited absolute effects of salt intake and obesity 
on brachial bP, a marked benefit could be gained by the 
bP effects of salt restriction and body weight reduction in 
African communities. SAHeart 2011; 8:28-36
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control of bP In AfrIcA And tHe World       
Other than in Canada where 80 to 86% of hypertensives of the 
population of the province of Ontario have BP values that are 
controlled to target,(11) there is little evidence to suggest that health-
care providers across continents are serious about controlling BP 
to currently accepted target levels (<140/90mm Hg).(2-4) Despite 
the fact that 21 to 59% of individuals within a wide range of 
populations have hypertension,(11-14) BP control rates are far below 
acceptable standards with 62 to 77% of hypertensives having an 
uncontrolled BP in the majority of developed countries.(12-15) The 
situation in economically emerging communities is far more 
disturbing, as 93% of black South African hypertensives may have 
a BP that is uncontrolled.(16) Hence, in countries where these 
national figures are available, hypertension is a neglected condi- 
tion. Globally, the level of disregard for the management of this 
silent, but catastrophic condition is unimaginable.
AfrIcAn HeAltHcAre systems under               
Pressure
It is now well accepted that Africa faces different healthcare 
challenges as compared to other continents because of a lack of 
resources and infrastructure and because of competition for 
healthcare resources through the burden of diseases of poverty, 
and the HIV/AIDS epidemic and its associated diseases. It is 
disappointing to say the least that in contrast to The Tobacco 
Products Act of 1993 and The Liquor Act of 2003 (act 59), which 
effectively limited the abuse of these substances, South Africa has 
not risen to the challenge of instituting cost-effective population 
interventions, which could considerably alleviate the burden of 
disease produced by BP effects.
Whilst at a national level in European countries, through pressure 
exerted at a number of levels, the food industry has reduced the 
salt content of their processed products, in countries such as South 
Africa this, to our knowledge, has only ever been discussed without 
concrete actions following suite. Furthermore, whilst education 
programmes have been instituted in a variety of European and 
North American countries at school and other levels to promote 
a decrease in calorie intake, or an increase in calorie expendi- 
ture, hence attempting to modify the emerging epidemic of 
obesity, there is no evidence at a national level in any African 
country that we are aware of, that these programmes are even 
being considered. We are dumbfounded by the national inertia in 
African countries in this regard, as by reducing BP at a national 
level using non-drug interventions could free up valuable health- 
care resources to further combat the HIV/AIDS epidemic and 
associated communicable diseases and prevent diseases of poverty. 
However, it is all very well being critical of healthcare providers if 
the evidence to support these notions in Africa is scanty.
Much of the reluctance to promote a healthier lifestyle in Africa 
may be derived from a distinct lack of substantial evidence to 
demonstrate the extent to which salt intake or obesity contributes 
toward the variation in BP at a population level on this continent. 
However, recent evidence has addressed some of these issues and 
concerns. In the following personal review we will discuss this 
evidence in the context of previous data originating from the 
African continent and other African populations.
sAlt IntAke And HyPertensIon In generAl    
Large cross-sectional studies indicate that dietary salt intake as 
indexed by increases in urinary Na+ excretion or increases in 
urinary Na+/K+, is associated with BP.(17-20) Moreover, intervention 
studies have demonstrated that reductions in Na+ intake decrease 
BP and the risk for hypertension.(21-26) As a consequence of 
these(17-26) and other findings, guidelines recommend that changes 
in salt intake should constitute part of lifestyle changes for the 
management of hypertension.(2-4) Nevertheless, it is important to 
note that the effect of salt intake on BP still generates contro- 
versy. In this regard, no long-term intervention studies have 
evaluated whether reductions in salt intake decrease cardiovas-
cular mortality and morbidity. Moreover, although the Dietary 
Approaches to Stop Hypertension (DASH) trial provides robust 
evidence to show that reductions in Na+ intake result in significant 
decreases in BP,(24,25) there are still a number of arguments against 
a strong role for salt in BP control. Indeed, the DASH study was 
conducted in a small study sample for a multicentre clinical trial 
(n = 412),(24,25) and other salt intervention studies were similarly 
conducted in relatively small study samples.(26) Furthermore, a 
meta-analysis of 57 trials derived from the Cochrane database 
with a considerable overall sample size (n = 9009), which included 
data from the DASH study, suggests that in Caucasians at least 
there is only a relatively small size effect on BP (-4.2 systolic [SBP] 
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and -2.0 diastolic [DBP] BP in hypertensives) of considerable 
reductions in salt intake.(26) These data are more in-line with the 
relatively small quantitative impact of salt intake on BP in the 
multicentre Intersalt study conducted in 52 centres across the 
world (n = 10 079).(16) Nevertheless, the relatively small quanti-
tative effect of salt intake on BP may only apply to the dominant 
ethnic groups assessed in many of these studies and that is, 
in Caucasian populations. What is the evidence that African 
populations consume excessive salt in their diet and is there better 
evidence for a role of salt intake in contributing toward a marked 
proportion of BP variability at a population level in African groups?
sAlt IntAke In AfrIcA                                                
In two studies with sample sizes of 110 to 291, the current evi-
dence points to a considerably greater quantity of Na+ being 
consumed by African populations than that recommended by 
guidelines,(27,28) even amongst hypertensives receiving antihyper-
tensive medication.(28) Furthermore, at least in the South African 
context, hypertensives are not receiving advice on how to reduce 
Na+ intake.(27,28) Extending the previous data obtained by our 
group from one of these studies,(28) Table 1 shows the mean 
24-hour urinary Na+ excretion values (an index of salt intake) in 
the largest database of 24-hour urinary salt excretion measure-
ments obtained in African populations (n = 640). Clearly, in 
South Africa at least, in urban developing communities of African 
ancestry, a significant proportion (68%) of people are consuming 
Na+ beyond the recommended daily allowance of 65mmol/day 
and 44.2% are consuming Na+ at a level that exceeds the more 
liberal target of 100mmol/day. Moreover, treated hypertensives 
consume a similar amount of Na+ as untreated hypertensives. 
There are many potential reasons why either healthcare pro-
fessionals or patients are reluctant to take to heart the 
recommendation to reduce Na+ intake. Importantly, what requires 
careful consideration is whether there is indeed significant evi-
dence to suggest that salt intake accounts for a considerable 
proportion of an increased BP in Africa.
WHAt Is tHe eVIdence to suPPort A mAjor      
effect of sAlt IntAke on bP In grouPs of      
AfrIcAn orIgIns? 
The evidence to support a relationship between salt intake and BP 
at a population level in Africa has, until recently, been almost 
non-existent. Three studies (n = 110, 169 and 291) have failed 
to show relationships between urinary salt excretion and BP in 
black South Africans.(27-29) Moreover, in the highly cited Intersalt 
study showing a relationship between urinary salt excretion and 
BP in an analysis of data obtained from 52 centres across the 
world (n = 10 079), the only data included in the analysis from 
Africa were from Zimbabwe (n = 195) and Kenya (n = 176) and 
the relationship between salt intake and BP in these population 
samples was either absent (Kenya) or weak at best (Zimbabwe).(21) 
Is there evidence from intervention studies to suggest that salt 
intake could contribute to a considerably greater proportion of 
BP variability in groups of African descent?
Importantly, in the DASH study, reductions in Na+ intake were 
particularly effective in people of black African ancestry (57% of 
the sample),(24,25) with a mean change in SBP of -8.1mm Hg in this 
ethnic group(25) and the meta-analysis of all studies with groups 
of black African descent similarly indicated that SBP decreased 
by -6.4mm Hg on a low Na+ diet.(26) However, the meta-ana- 
lysis(26) suggested that there was insufficient data to draw 
conclusions on the impact of decreases in Na+ intake on BP in 
groups of African descent. Indeed, as compared to data from the 
8 487 Caucasians that could be included in the meta-analysis, 
data from only 522 participants of black African descent could 
be included.(26)
HypErtEnsion in AfricA
tAble 1: Daily (24-hour) sodium (na+) intake as determined from 24-
hour urinary na+ excretion, the proportion of people with 24-hour na+ 
intake above the recommended daily allowance of 65mmol/day, and the 
proportion of people with 24-hour na+ intake above 100mmol/day in a 
community sample of African ancestry (African programme on Genes in 
Hypertension) (see references(30,42,44-48) for study design and details).
*body mass index≥30kg/m2
 Urinary na+ % with urinary  
  na+ excretion
 Mean (±sD)  >65 >100 
 (mmol/day)  mmol/day mmol/day
All participants (n = 640) 105±73 68% 44%
Treated hypertensives (n = 156)  89±59 62% 37%
Untreated hypertensives (n = 154) 106±79 64% 42%
Obese* (n = 273) 103±68 69% 42%
Non-obese (n = 367) 107±77 68% 46%
Men (n = 222) 111±73 68% 50%
Women (n = 418) 102±73 68% 41%
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Despite some evidence in favour of a greater effect of Na+ 
reduction on BP in groups of African descent as compared to 
alternative groups, neither the DASH,(24,25) nor any other study 
included in the recent meta-analysis(26) evaluated the effect of a 
reduced Na+ intake on participants from the African continent. 
Although this may appear to be a trivial omission in the eyes of 
some, it is well recognised that the capacity to reduce BP on a 
low Na+ diet differs enormously from individual to individual, 
possibly because of differences in the renal handling of salt. 
This may occur to the extent that whilst in some individuals BP 
decreases considerably in response to a reduced Na+ intake, in 
others BP may even increase on a low Na+ diet. Is this a factor 
that needs careful consideration? Indeed, our group in collabora-
tion with colleagues on the European continent, has provided 
evidence to indicate that the genetic factors that contribute 
toward the renal handling of salt are markedly different in black 
African populations in South Africa as compared to European 
populations.(30) The obvious question therefore is what explains 
the previous evidence to show a lack of relationship between 
urinary indices of salt intake and BP in groups of African ancestry 
in South Africa?(27-29)
neW eVIdence for sAlt effects on bP In        
grouPs of AfrIcAn Ancestry
There are many experts who believe that despite measures of 
urinary Na+ excretion being substantially better measures of salt 
intake than dietary recall, a lack of relationship between urinary 
indices of salt intake and BP in Africa(27-29) may reflect the inability 
of these measures to fully capture actual salt intake. However, 
we have recently hypothesised that the main effect of salt intake 
is on pulse pressure (SBP – DBP), the dynamic component of 
BP and that this effect is possibly best detected in the aorta 
(central BP).(31) This hypothesis is derived from previous data to 
indicate that despite reductions in Na+ intake producing marked 
SBP effects, either no significant effect(26) or only a comparatively 
modest effect(25) on DBP may occur.
Our recent data(30) provide clear evidence in 635 randomly 
recruited participants from the African Programme on Genes in 
Hypertension (APOGH) to show that in an urban community of 
African ancestry (South West Township of Gauteng [SOWETO]), 
a urinary index of salt intake is strongly and independently related 
to central (aortic) SBP and pulse pressure. The independent 
relationship between a urinary index of salt intake and brachial 
artery pressures in this study was weak at best and no relationship 
with DBP was noted.(31) The difference in the impact of salt intake 
on central aortic and peripheral brachial BP can be attributed 
to the marked differences in the pathophysiological determinants 
of brachial and aortic pulse pressure and SBP. What are the 
implications of these data for South Africa and possibly Africa as 
a whole?
ImPlIcAtIons for AfrIcA of tHe ImPAct of      
sAlt IntAke on centrAl (AortIc) bP
Even in the context of the limitation of being unable to fully 
capture the impact of salt intake on BP from 24-hour urinary salt 
excretion data, our data nevertheless provide the first convincing 
evidence that abnormalities in salt intake are indeed independently 
associated with BP in groups of African ancestry in Africa.(31) 
Although our study was an association study, and hence only 
implies a cause-effect relationship, the sample size (n = 635) and 
the probability values (p<0.0001) for an association between a 
urinary index of salt intake and central BP demonstrated in this 
study(31) cannot be considered to occur by chance. Thus, the effects 
of salt intake on BP may have previously been underestimated in 
African populations.(27-29) The robust relationships between a 
urinary index of salt intake and central aortic BP in groups of African 
ancestry(31) is consistent with the higher lymphocyte Na+ content 
previously reported to occur in hypertensives as compared to 
normotensives of African descent.(32) From the data obtained in the 
APOGH study,(31) we suggest that salt intake will increase aortic 
SBP 1.45 times more than it will brachial BP. Hence, if we assume 
that a reduction in Na+ intake of 100mmol/day (3.7g Na+ per day 
which equates to 9.2g or about 4 teaspoons of table salt per day) 
reduces brachial SBP by -8.1mm Hg in groups of African descent 
as suggested by the DASH study,(25) then presumably aortic SBP 
may decrease by as much as 11.8mm Hg in response to a decrease 
in Na+ intake. Only intervention studies will be able to assess this 
hypothesis.
The second implication of the finding that salt intake is related to 
aortic SBP, with minimal effects on brachial BP in the APOGH 
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study,(31) is that there is now increasing evidence that central 
pressures predict cardiovascular events and damage beyond 
brachial artery BP.(33-37) Therefore, there is a distinct possibility that 
an excess salt intake produces cardiovascular damage that exceeds 
that predicted by conventional BP measurements. Is there evidence 
for similar effects of aortic beyond brachial BP on cardiovascular 
damage in African populations? In this regard, we have demon-
strated in the APOGH study that factors which contribute toward 
central pressures are indeed associated with left ventricular mass 
independent of brachial pressure.(38) As there is no question that 
left ventricular mass predicts cardiovascular outcomes beyond 
brachial BP, we assume that this evidence translates into outcomes 
as well. Thus, we believe our data provide convincing support for 
a need to reduce Na+ intake to achieve optimal BP values in 
groups of African ancestry in South Africa. Nevertheless, inter-
vention studies are required to provide a higher level of evidence 
to support these data.
The third implication of the finding that salt intake affects aortic 
SBP, with minimal effects on brachial BP in the APOGH study,(31) 
relates to potential therapy. In this regard, there is little evidence 
for a strong central pulse pressure lowering effect of any currently 
recommended anti-hypertensive agent beyond that produced by 
decreases in static BP (mean arterial pressure). Thus, presently 
there may be no real alternative to treating Na+ induced increases 
in central BP independent of static pressures, but to reduce Na+ 
intake.
A word of caution is required regarding the implications of the 
findings that salt intake is related to aortic SBP, with minimal effects 
on brachial BP in the APOGH study.(31) These results do not suggest 
that central aortic BP measurements should replace brachial artery 
BP measurements when assessing the effects of reduction in salt 
intake on BP. The use of costly technology such as that required to 
measure aortic BP is unlikely to improve adherence to anti-
hypertensive (including lifestyle) treatment. Furthermore, whether 
this technology is cost-effective is a question that requires con-
siderably more research to answer. The finding that salt intake is 
related to aortic SBP, with minimal effects on brachial BP,(31) 
may nevertheless lend a degree of confidence in the efficacy of 
the effect of Na+ restriction on BP when only small decreases in 
brachial BP occur. 
obesIty And HyPertensIon In generAl             
There is now substantial evidence from population-based studies 
with large study samples (n = 10 969 to 15 063) conducted out 
of Africa in favour of obesity being a major determinant of BP 
and the development of hypertension.(39,40) Indeed, the odds of 
developing hypertension are 1.7 to 3.4 times greater in obese 
individuals as compared to lean individuals.(40) Further, there is 
considerable evidence also obtained out of Africa to indicate that 
weight reduction results in decreases in BP. In a meta-analysis of 
a number of weight reduction studies, with a total sample size of 
4 874 participants, the estimated decrease in BP that will occur 
for every 5.1kg loss of weight over 16 months was 3.5 to 4.5mm 
Hg.(41) Moreover, in the Atherosclerosis Risk in Communities 
(ARIC) study involving 3 245 participants, a 1.5 to 2.0 fold chance 
of hypertension remission was reported to occur for every 1kg 
decrease in body weight over 9 years.(42)
WHAt Is tHe eVIdence to suPPort A mAjor       
effect of obesIty on bP In AfrIcA?
Despite the emerging epidemic of obesity in black African 
populations in South Africa,(43) the size effect of excess adiposity on 
ambulatory (an assessment of BP that discounts alerting responses, 
includes 24-hour BP profiles and excludes observer bias) and 
conventional BP in African populations has only recently been 
reported on by our group in the APOGH study in 300 participants, 
65% of whom were either overweight or obese and 42% of whom 
were hypertensive.(44) In this regard, after multiple adjustments, 
every 15cm (one standard deviation) increase in waist circumference 
(the index of adiposity most closely related to BP) was associated 
with a 4.04mm Hg increase in 24-hour systolic BP and a 4.33mm 
Hg increase in 24-hour diastolic BP.(44) Moreover, after multiple 
adjustments, every 15cm (one standard deviation) increase in waist 
circumference was associated with a 3.35mm Hg increase in 
conventional SBP and a 3.27mm Hg increase in conventional 
DBP.(44) It should be obvious that the impact of large changes in 
central adiposity, only produce modest effects on BP.
It may be argued that the relatively limited impact of excessive 
adiposity on BP reported on in the APOGH study(44) may reflect an 
inadequate sample size (n = 300). Therefore, extending these 
previous data on relationships between indices of adiposity and 
HypErtEnsion in AfricA
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conventional or ambulatory BP from our group.(44) Table 2 shows 
the impact of increases in either waist circumference or body 
mass index on conventional or 24-hour BP evaluated in a much 
larger study sample of randomly recruited participants of African 
descent in the APOGH with 24-hour ambulatory BP values that 
met with pre-specified quality control criteria (n = 657). Import-
antly, these data represent the largest study conducted so far 
assessing the impact of an excess adiposity on BP in African 
populations. Even with a significant study sample for an ambulatory 
BP study, in South Africa at least the independent impact of 
adiposity on BP in groups of African descent is remarkably small. 
These data raise the question of exactly how effective major efforts 
at reducing excess adiposity in Africa would be at achieving BP 
related decreases in cardiovascular risk at a population level. In 
this regard, despite the data from APOGH (Table 2), there are a 
number of reasons why we believe that promoting weight loss 
will substantially reduce BP related cardiovascular risk, hypotheses 
that nevertheless still need to be further explored. The following 
discussion outlines these arguments.
genetIc modIfIers of obesIty effects on bP 
We have recently demonstrated that the impact of an excessive 
adiposity on BP may in fact be genetically pre-determined.(45) Thus, 
it is possible that in certain pre-identified obese individuals, weight 
loss programmes may have profound effects on BP and that as 
long as these as opposed to alternative individuals are targeted 
for weight loss programmes, far more substantial effects of weight 
loss on decreases in BP could be produced than those estimated 
at a community level by our group. At present, in further studies 
we are attempting to identify the impact of body mass index or 
waist circumference on conventional and 24-hour BP at a com-
munity level in genotype-specific groups and to identify the exact 
mechanism of this genetic effect on obesity-BP relations. Importantly 
however, weight loss studies are required in genotype-specific 
groups to provide convincing evidence of these effects.
blood Pressure And An excess AdIPosIty          
Act In synergy to Account for                            
cArdIoVAsculAr dAmAge
There is now substantial evidence to indicate that obesity 
contributes toward cardiovascular outcomes and damage beyond 
both BP and alternative cardiovascular risk factors. This topic goes 
beyond the present review. Importantly, the additive effects of 
obesity on cardiovascular damage in other populations is now 
well supported by evidence obtained in African communities(5) 
including the APOGH study.(46-49) However, we have also recently 
considered the possibility that the deleterious effects of obesity 
occur in synergy with BP. Is there evidence to support this notion?
tAble 2: impact of one standard deviation (sD) increase in waist circumference (Wc) or body mass index (BMi) on multivariate adjusted conventional or 
24-hour systolic (sBp) or diastolic (DBp) blood pressure in a community sample of African ancestry (African programme on Genes in Hypertension) 
(see references(30,42,44-48) for study design and details). importantly, in this study 44.6% had central (abdominal) obesity and 42.5% had a BMi≥30kg/m2.
* Calculated from the ß-coefficient (slope) of the relationship between either WC or BMI and BP. All data are adjusted for age, sex, regular smoking, regular alcohol consumption, diabetes mellitus 
or an HbA1c>6.1%, menopausal status in women and antihypertensive therapy (only in all participants).
 one sD Wc    Bp effect* one sD BMi  Bp effect* 
  All participants
Conventional SBP (n = 1029) 16.3cm 2.31mm Hg 8.03kg/m2 2.52mm Hg 
Conventional DBP (n = 1029) 16.3cm 2.33mm Hg 8.03kg/m2 2.26mm Hg
24-hour SBP (n = 657) 15.5cm 2.55mm Hg 7.68kg/m2 2.61mm Hg
24-hour DBP (n = 657) 15.5cm  1.15mm Hg 7.68kg/m2 0.84mm Hg
 participants not receiving antihypertensive therapy, 29.6% of whom were hypertensive
Conventional SBP (n = 787) 15.7cm 2.69mm Hg 7.57kg/m2 2.76mm Hg 
Conventional DBP (n = 787) 15.7cm 2.82mm Hg 7.57kg/m2 3.07mm Hg
24-hour SBP (n = 533)  15.1cm 2.77mm Hg 7.30kg/m2 2.80mm Hg
24-hour DBP (n = 533) 15.1cm 1.06mm Hg 7.30kg/m2 1.05mm Hg
34
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In the APOGH study in a group of African ancestry, we have 
demonstrated that marked synergy between indices of adiposity 
(waist circumference and skin-fold thickness) and either con-
ventional, aortic or 24-hour SBP or pulse pressure is independently 
associated with left ventricular mass and mean wall thickness.(50) 
These synergistic effects were noted after multivariate adjust- 
ments including adjustments for the individual adiposity indices 
and haemodynamic variables.(50) These synergistic effects translated 
into a greater impact of SBP or pulse pressure on left ventricular 
mass and mean wall thickness in participants with an increased as 
compared to a normal waist circumference.(50) Indeed, for equiva-
lent increases in SBP, as compared to participants with a normal 
waist circumference, participants with a high waist circumference 
had a 3 to 4 times greater increase in left ventricular mass after 
adjustments for confounders.(50) Moreover, left ventricular mass 
was only increased in participants with both an increased waist 
circumference and an increased SBP, whilst participants with just 
an increased BP did not have an increased left ventricular mass.(50)
Although in the APOGH we were able to show distinct synergy 
between obesity and BP as a determinant of left ventricular mass,(50) 
this was a cross-sectional study and hence we are unable to draw 
conclusions regarding cause and effect. In order to provide further 
proof of principle, we therefore performed a prospective study in 
an animal model of hypertension.(51) In this regard, a dietary inter-
vention that promoted visceral obesity similarly resulted in a 
marked further increase in left ventricular weight in hypertensive, 
but no effect on left ventricular weight in normotensive rats, the 
consequence being that in the hypertensive rats, cardiac dilatation 
and pump dysfunction occurred.(51) These data lend further support 
for the concept that an excess adiposity may enhance the adverse 
effects of BP on cardiovascular damage. Thus, although obesity may 
not account for a significant proportion of the variability of BP in 
groups of African ancestry, the purpose of targeting obesity may 
be to decrease the adverse impact of BP on the heart. Under 
these circumstances it is possible that even modest BP reductions 
achieved by weight loss may translate into major benefits on 
cardiovascular damage. However, weight loss studies are required 
to test this hypothesis.
summAry And conclusIons                                    
Despite the poor BP control that occurs in communities of 
African ancestry in Africa,(16) and the possibility that improved 
drug treatment may not occur because of therapeutic inertia by 
healthcare providers and competing healthcare resources, there is 
little evidence for actions being taken at a national level to reduce 
BP related cardiovascular damage through an improved lifestyle. 
However, criticism should not be levelled until all the facts are 
available. The present review argues from recent strong data that 
there is now indeed significant evidence to suggest that modifying 
salt intake and promoting weight reduction may reduce cardio-
vascular risk related to BP in urban, developing communities of 
African descent and these benefits may occur well beyond that 
predicted by conventional (brachial artery) BP measurements 
alone. Indeed, the available evidence suggests that the deleterious 
effects of salt intake and central obesity on BP related cardiovas-
cular damage may not be easily discernable from conventional 
BP measurements. 
The time is right for initiating large (at least comparable with the 
DASH study in the sample size), controlled intervention studies 
designed to reduce salt intake and decrease body weight in groups 
of African descent in Africa in order to assess the extent to which 
these interventions may reduce BP related cardiovascular risk. In 
this regard, these studies will not be of significant value if small 
study samples are employed, as convincing evidence is required 
in a study that represents a significant proportion of the black 
African population. The ideal would be a study that assesses car-
diovascular outcomes, but with the present low quality reporting 
of causes of death in many areas of South Africa, this approach is 
likely to be of little value.
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